The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 38.29 USD. With the latest stock price at 25.82 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 48.3%.
Based on the latest price of 25.82 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 48.3%.
Range | Selected | |
WACC / Discount Rate | 6.6% - 9.8% | 8.2% |
Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
Fair Price | 28.84 - 54.91 | 38.29 |
Upside | 11.7% - 112.7% | 48.3% |